A double-blind, placebo-controlled, crossover, study to evaluate the efficacy of subcutaneous sumatriptan in the treatment of atypical facial pain

International Journal of Neuroscience

Volumn 86, Issue 3-4, 1996, Pages 301-309

  Al Balawi, Saeed ^a   Tariq, Mohammad ^a   Feinmann, Charlotte ^b  

^a Prince Sultan Military Medical City   (Saudi Arabia)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Atypical facial pain; double blind trial; efficacy; safety; sumatriptan

Indexed keywords

EID: 0030240354     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207459608986720     Document Type: Article

References (30)

1. 1-like receptor agonist. British Journal of Pharmacology, 96, 379-87.
2. Davis, L. & Pollock, L. J. (1932). The role of the sympathetic nervous system in the production of pain in the head. Archives of Neurology and Psychiatry, 27, 282-93.
3. Derbyshire, S. W. G., Jones, A. K. P., Devani, P., Friston, K. J , Feinmann, C., Harris, M., Pearce, S., Watson, J. D. O. & Frackowiak, R. S. J. (1994). Cerebral responses to pain in patients with atypical facial pain measured by positron emission tomography. Journal of Neurology, Neurosurgery and Psychiatry, 571, 1166-72.
4. Donoghue, S., Durham, J. M., Yates, S. A. & Endersby, C. (1989). A double-blind study to compare the efficacy of subcutaneous GR43175C with that of subcutaneous placebo injection in the acute treatment of migraine. Glaxo Group Research Report Number GCV/89/006.
5. Drummond, P. D. (1988). Vascular changes in atypical facial pain. Headache, 28, 121-3.
6. Edvinsson, L & Jansen, I. (1989). Characterization of 5-HT receptors mediating contraction of human cerebral, meningial and temporal arteries: target for GR43175 in acute treatment of migraine. Cephallagia, 9 (suppl 10), 39-40.
7. Engel, G. L. (1959). Psychogenic pain and the pain prone patient. American Journal of Medicine, 196, 129-36.
8. Evans, F. J. (1981). The placebo response in pain control. Psychopharmacology Bulletin, 17, 72-6.
9. Feinmann, C. & Harris, M. (1984). Psychogenic facial pain, Part I: the clinical presentation. British Dental Journal, 156, 165-8.
10. Feinmann, C., Harris, M. & Cawley, R. Psychogenic facial pain: presentation and treatment. British Medical Journal, 288, 436-8.
11. Feniuk, W., Humphrey, P. P. A. & Perrer, M. J. (1989). The selective carotid vasoconstrictor actions of GR43175 in anaesthetized dogs. British Journal of Pharmacology, 96, 83-90.
12. Frazier, C. H. & Russell, E. C. (1924). Neuralgia of the face An analysis of 754 cases with relation to pain and other sensory phenomena before and after operation. Archives of Neurology and Psychiatry, 11, 557-63.
13. Gabriel, M , Orona, E., Foster, K. & Lambert, R. W. (1982). Mechanisms and generality of stimulus significance coding in a mammalian model system. Advances in Behavioral Biology, 26, 535-67.
14. 1-like receptor in the dog isolated saphenous vein. British Journal of Pharmacology, 94, 1123-32.
15. Hunter, S. (1994). Atypical facial pain - rewarding to treat. The Practitioner, 238, 186-193.
16. Koch, G. G. (1972). The use of non-parametric methods in the statistical analysis of the two-period changeover design. Applied Statistics, 36, 192-204.
17. Kuhn, R. (1958). The treatment of depression state with imipramine hydrochloride. American Journal of Psychiatry, 115, 459-64.
18. Lacelles, R G. (1966). Atypical facial pain and depression. British Journal of Psychiatry, 112, 651-59.
19. Lesse, S. (1956). Atypical facial pain syndrome of psychogenic origin. Journal of Nervous and Mental Diseases, 124, 341-6
20. McCarthy, B. G. & Peroutka, S. J. (1989). Comparative neuropharmacology of dihydroergotamine and sumatriptan (GR43175). Headache, 29, 420-2
21. Melzack, R. (1987). The short-form McGill Pain Questionnaire. Pain, 30, 191-7.
22. Moore, D. S. & Nally, F. F. (1975). Atypical facial pain. An analysis of 100 patients with discussion. Journal of Canadian Dental Association, 7, 396-401.
23. Moskowitz, M. A. (1992). Neurogenic venus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends in Pharmacological Sciences, 13, 307-11.
24. Pardo, J. V., Pardo, P J., Janer, K. W. & Raichle, M. E. (1990). The anterior arigulate cortex mediates processing selection in the stroop attentional conflict paradigm. Neurobiology, 87, 256-9.
25. Peroutka, S. J. & McCarthy, B G. (1989). Sumatriptan (GR43175) interacts selectively with 5-HT 1B and 5-HT 1D binding sites European Journal of Pharmacology, 163, 133-6.
26. Peroutka, S. J., Switzer, J. A. & Hanik, A. (1989). Identification of 5-hydroxytryptamine 1 D binding sites in human brain membrane. Synapse, 3, 61-6.
27. Pozos, A., Probot, A. & Palacio, J. M. (1987). Serotonin receptors in the human brain: III Autoradiagraphic mapping of serotonin-1 receptors. Neuroscience, 21, 97-122.
28. Reik, L. R. Jr. (1985). Atypical facial pain. A reappraisal Headache, 25, 30-2.
29. Remick, R. H., Blasberg, B., Barton, J. S., Campos, P E. & Miles, J. E. (1983). Ineffective dental and surgical treatment association with atypical facial pain. Oral Surgery, 55, 355-8.
30. Remick, R. H. & Blasberg, B. (1985). Psychogenic aspect of atypical facial pain. Canadian Dental Association, 51, 913-15.